Advertisement
  • Young Colorectal Cancer Patients Are Often Misdiagnosed

    A new survey suggests that young adults with colorectal cancer struggle to receive an accurate, prompt diagnosis.

    by Bradley Jones

  • February 22: The Week in Cancer News

    Trials indicate that a combination of a targeted therapy and immunotherapy can treat advanced kidney cancer, and a study identifies a genetic variant associated with smoking menthol cigarettes.

    by Kate Yandell

  • February 15: The Week in Cancer News

    Guidelines recommend that all breast cancer patients be offered genetic testing, and a report indicates that disparities in cancer incidence and mortality between black and white Americans are getting smaller.

    by Kate Yandell

  • Considering the Term “Cancer Survivor”

    A study investigates how people who have been diagnosed with cancer feel about being called survivors.

    by Jen Tota McGivney

  • February 8: The Week in Cancer News

    A study finds that a new shingles vaccine is safe and likely effective in adult cancer patients, and a review article shows that some cancer patients with HIV can benefit from immunotherapy.

    by Kate Yandell

  • Making Clinical Trials More Inclusive

    Broadening clinical trial eligibility criteria to include cancer patients who also have other health conditions could increase trial enrollment.

    by Ashley P. Taylor

  • February 1: The Week in Cancer News

    Unsupported claims of a “complete cure” for cancer spread across the internet and airwaves, and a new policy aims to increase inclusion of older patients in research.

    by Kate Yandell

  • January 25: The Week in Cancer News

    A trial finds that it is safe to take a hormone-blocking drug to reduce prostate cancer risk, and direct-to-consumer genetic testing for cancer risk factors expands.

    by Kate Yandell

  • What Do Clinical Trial Endpoints Really Measure?

    A study investigates whether a commonly used clinical trial endpoint, progression-free survival, can be used to predict quality of life.

    by Jon Kelvey

  • January 18: The Week in Cancer News

    A study sheds light on predicting immunotherapy response, and a company starts testing a digital chemotherapy pill.

    by Kate Yandell